Profil
Lisa Sinclair is Senior Vice President-Corporate Operations at Arvinas, Inc. since 2022.
Formerly, Ms. Sinclair was VP-Global R&D Portfolio & Performance at AstraZeneca, Inc., Head-Programs & Alliance Management at Springworks Therapeutics, Inc., and Head-Corporate & Commercial Strategy at Rallybio Corp.
Education includes undergraduate studies at the University of Vermont.
Postes actifs de Lisa Sinclair
| Sociétés | Poste | Début |
|---|---|---|
| ARVINAS, INC. | Directeur des opérations | 15/08/2022 |
Anciens postes connus de Lisa Sinclair
| Sociétés | Poste | Fin |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Corporate Officer/Principal | - |
| RALLYBIO CORPORATION | Corporate Officer/Principal | - |
Formation de Lisa Sinclair
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Springworks Therapeutics, Inc.
Springworks Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for treating cancer | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
















